Regulon

Regulon: R-1598

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
181.98313124Pr-108Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9369 ENSG00000021645 NRXN3 Q9HDB5
4345 ENSG00000091972 CD200 F8W7G1
26033 ENSG00000107518 ATRNL1 Q5VV63
79176 ENSG00000107872 FBXL15 Q9H469
7164 ENSG00000111907 TPD52L1 Q16890
3241 ENSG00000115756 HPCAL1 P37235
311 ENSG00000122359 ANXA11 P50995
9467 ENSG00000131370 SH3BP5 O60239
9645 ENSG00000133816 MICAL2 O94851
6775 ENSG00000138378 STAT4 Q14765
9922 ENSG00000144711 IQSEC1 Q6DN90
783 ENSG00000165995 CACNB2 Q08289
5604 ENSG00000169032 MAP2K1 A0A8I5QJL9
25924 ENSG00000170011 MYRIP Q8NFW9
8534 ENSG00000175264 CHST1 O43916
5464 ENSG00000180817 PPA1 Q15181
2903 ENSG00000183454 GRIN2A Q12879
29 ENSG00000278741 ABR Q12979

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
TERODILINECACNA1DSmall moleculeBLOCKERVoltage-gated calcium channel blocker40
ACAMPROSATE CALCIUMGABRG2Small moleculePOSITIVE MODULATORGABA-A receptor; anion channel positive modulator40
MIRDAMETINIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor20
AV-101GRIN1Small moleculeANTAGONISTGlutamate [NMDA] receptor antagonist20
BINIMETINIBMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor40
MEMANTINEGRIN1Small moleculeNEGATIVE ALLOSTERIC MODULATORGlutamate [NMDA] receptor negative allosteric modulator42
DEXTROMETHORPHAN HYDROBROMIDEGRIN2ASmall moleculeAGONISTSigma opioid receptor agonist40
COBIMETINIB FUMARATEMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor40
RO-4987655MAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor10
MEMANTINE HYDROCHLORIDEGRIN1Small moleculeNEGATIVE ALLOSTERIC MODULATORGlutamate [NMDA] receptor negative allosteric modulator40
COBIMETINIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor40
ORPHENADRINE HYDROCHLORIDESCN2ASmall moleculeBLOCKERSodium channel alpha subunit blocker40
WX-554MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor10
AZD-8330MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor10
SELUMETINIB SULFATEMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor43
PIMASERTIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor20
SELUMETINIBMAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor43
NERAMEXANEGRIN1Small moleculeANTAGONISTNeuronal acetylcholine receptor; alpha9/alpha10 antagonist30
KETAMINEGRIN1Small moleculeNEGATIVE ALLOSTERIC MODULATORGlutamate [NMDA] receptor negative allosteric modulator40
E-6201MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor20
DEXTROMETHORPHAN POLISTIREXGRIN2ASmall moleculeANTAGONISTGlutamate [NMDA] receptor subunit epsilon 1 antagonist40
DEXTROMETHORPHANGRIN2ASmall moleculeAGONISTSigma opioid receptor agonist40
SAMALIZUMABCD200AntibodyINHIBITOROX-2 membrane glycoprotein inhibitor20
ORPHENADRINESCN2ASmall moleculeBLOCKERSodium channel alpha subunit blocker40
TRAMETINIBMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor41
GABAPENTIN ENACARBILCACNA1DSmall moleculeMODULATORVoltage-gated calcium channel modulator40
FELBAMATEGRIN1Small moleculeANTAGONISTGlutamate [NMDA] receptor antagonist40
AMANTADINE HYDROCHLORIDEGRIN1Small moleculeANTAGONISTGlutamate [NMDA] receptor antagonist40
PREGABALINCACNA1DSmall moleculeMODULATORVoltage-gated calcium channel modulator40
RAPASTINELGRIN1ProteinPARTIAL AGONISTGlutamate [NMDA] receptor partial agonist30
ATAGABALINCACNA1DSmall moleculeMODULATORVoltage-gated calcium channel modulator20
GABAPENTINCACNA1DSmall moleculeMODULATORVoltage-gated calcium channel modulator40
LANICEMINEGRIN1Small moleculeBLOCKERGlutamate [NMDA] receptor blocker20
ACAMPROSATEGABRG2Small moleculePOSITIVE MODULATORGABA-A receptor; anion channel positive modulator40
REFAMETINIBMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor20
RALFINAMIDEMAOBSmall moleculeINHIBITORMonoamine oxidase B inhibitor30
BEPRIDILCACNA1DSmall moleculeBLOCKERVoltage-gated calcium channel blocker40
SULOCTIDILCACNA1DSmall moleculeBLOCKERVoltage-gated calcium channel blocker40
GW468816GRIN1Small moleculeANTAGONISTGlutamate [NMDA] receptor antagonist20
NERAMEXANE MESYLATEGRIN1Small moleculeANTAGONISTNeuronal acetylcholine receptor; alpha9/alpha10 antagonist30
IMAGABALINCACNA1DSmall moleculeMODULATORVoltage-gated calcium channel modulator30
ORPHENADRINE CITRATESCN2ASmall moleculeBLOCKERSodium channel alpha subunit blocker40
APIMOSTINELGRIN1ProteinPARTIAL AGONISTGlutamate [NMDA] receptor partial agonist20
CI-1040MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 1 inhibitor20
ESKETAMINEGRIN1Small moleculeNEGATIVE ALLOSTERIC MODULATORGlutamate [NMDA] receptor negative allosteric modulator40
INDANTADOLGRIN1Small moleculeINHIBITORMonoamine oxidase A inhibitor20
ESKETAMINE HYDROCHLORIDEGRIN1Small moleculeNEGATIVE ALLOSTERIC MODULATORGlutamate [NMDA] receptor negative allosteric modulator40
AMANTADINEGRIN1Small moleculeANTAGONISTGlutamate [NMDA] receptor antagonist40
TRAMETINIB DIMETHYL SULFOXIDEMAP2K2Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor40
KETAMINE HYDROCHLORIDEGRIN1Small moleculeNEGATIVE ALLOSTERIC MODULATORGlutamate [NMDA] receptor negative allosteric modulator40
TAK-733MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor10
AS-703988MAP2K1Small moleculeINHIBITORDual specificity mitogen-activated protein kinase kinase 2 inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1598

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-02198OR4N2up-regulatesTCF3repressesR-1598182Drugs (52)
CMF-03171WDR90up-regulatesTCF3repressesR-1598183Drugs (52)
CMF-06297AFF2up-regulatesTCF3repressesR-1598185Drugs (52)
CMF-07576AHNAK2up-regulatesTCF3repressesR-1598185Drugs (52)
CMF-15584SASH1down-regulatesTCF3repressesR-1598183Drugs (52)
CMF-17660DOCK5up-regulatesTCF3repressesR-1598182Drugs (52)
CMF-22028WNT2up-regulatesTCF3repressesR-1598182Drugs (52)
CMF-34181OR4N2up-regulateshsa-mir-32repressesR-159811Drugs (52)
CMF-35944MAGup-regulateshsa-mir-181drepressesR-1598311Drugs (52)
CMF-36814RBM47down-regulateshsa-mir-636repressesR-159811Drugs (52)
CMF-37150KCNT1up-regulateshsa-mir-32repressesR-159811Drugs (52)
CMF-38036PTENdown-regulateshsa-mir-636repressesR-159811Drugs (52)
CMF-38038PTENdown-regulateshsa-mir-32repressesR-159811Drugs (52)
CMF-38040PTENdown-regulateshsa-mir-641repressesR-159882Drugs (52)
CMF-38053KCNQ5up-regulateshsa-mir-32repressesR-159811Drugs (52)
CMF-38070OR51F1up-regulateshsa-mir-181drepressesR-1598311Drugs (52)
CMF-38548TBX5down-regulateshsa-mir-636repressesR-159811Drugs (52)
CMF-38555TBX5down-regulateshsa-mir-32repressesR-159811Drugs (52)
CMF-39052NWD1up-regulateshsa-mir-641repressesR-159881Drugs (52)
CMF-39891IGFN1up-regulateshsa-mir-181drepressesR-1598311Drugs (52)
CMF-39892IGFN1up-regulateshsa-mir-641repressesR-159881Drugs (52)
CMF-40303ENPP7down-regulateshsa-mir-636repressesR-159811Drugs (52)
CMF-41040PLAC1Ldown-regulateshsa-mir-636repressesR-159811Drugs (52)
CMF-42713NPHS1up-regulateshsa-mir-181drepressesR-1598311Drugs (52)